As the above results indicated that compound 2 slightly attenuated tNOX expression and reduced the intracellular NAD+/NADH ratio by engaging with tNOX in HCC cells, we next sought to understand the cellular outcomes of these changes. The gene discussed is ENOX2; the disease is hepatocellular carcinoma.